# Possible Role of Gingival Crevicular Fluid Levels of Chemerin and Fibroblast Growth Factor 21 as Biomarkers of Periodontal Disease in Diabetic and Non-diabetic Patients

> **NCT04012983** · — · COMPLETED · sponsor: **Cairo University** · enrollment: 45 (actual)

## Conditions studied

- Periodontal Disease (Diagnosis)
- Diabetes Mellitus, Type 2

## Interventions

- **DIAGNOSTIC_TEST:** gingival crevicular fluid level

## Key facts

- **NCT ID:** NCT04012983
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04012983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04012983, "Possible Role of Gingival Crevicular Fluid Levels of Chemerin and Fibroblast Growth Factor 21 as Biomarkers of Periodontal Disease in Diabetic and Non-diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04012983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*